financetom
Business
financetom
/
Business
/
OpenAI responds to warnings of self governance by former board members, the Economist reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI responds to warnings of self governance by former board members, the Economist reports
May 30, 2024 12:52 PM

May 30 (Reuters) - OpenAI's board on Thursday pushed

back on allegations from its former members that concerns over

artificial intelligence safety at the startup necessitated Sam

Altman's shocking ouster last year.

OpenAI's board members in an article published in the

Economist said the review into the events found the previous

board's decision did not arise out of concerns over the pace of

AI development or statements made to the startup's investors,

customers or business partners, among others.

"In six months of nearly daily contact with the company, we

have found Altman highly forthcoming on all relevant issues and

consistently collegial with his management team," it said.

Helen Toner and Tasha McCauley, who had left the board in

November when Altman returned as CEO, had told the Economist in

an invitation piece on Sunday that they stood by the decision to

dismiss Altman, given the board's duty to "provide independent

oversight and protect the company's public-interest mission."

They also said that developments since their departure bode

ill for OpenAI's experiment in self-governance, pointing to

Altman's return to the Microsoft ( MSFT )-backed startup's

board, as well as the departure of senior safety-focused talent.

OpenAI's board, chaired by former Salesforce co-CEO Bret

Taylor, said it agreed with Toner and McCauley's view that AI

requires effective regulation and added that the ChatGPT maker

has held talks with government officials on various issues

surrounding generative AI.

OpenAI said on Tuesday it formed a safety and security

committee that will be led by board members as it begins

training its next AI model.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
InRetail Shopping Malls Announces the Expiration and Results of Abbreviated Tender Offer for any and all of its 5.750% Senior Notes due 2028
InRetail Shopping Malls Announces the Expiration and Results of Abbreviated Tender Offer for any and all of its 5.750% Senior Notes due 2028
Oct 10, 2025
LIMA, Perú, Oct. 10, 2025 /PRNewswire/ -- Patrimonio en Fideicomiso―D. Leg. No. 861, No Inscrito en la SMV, Dirigido a Inversionistas Institucionales—InRetail Shopping Malls, a Peruvian trust, acting through its trustee, Internacional de Títulos Sociedad Titulizadora S.A. (the Company, or InRetail Shopping Malls) announced today the expiration, at 5:00 p.m., New York City time, on October 9, 2025 (the Expiration...
Operational Challenges Slow Mosaic's Phosphate Division Progress
Operational Challenges Slow Mosaic's Phosphate Division Progress
Oct 10, 2025
Mosaic Company ( MOS ) shares traded significantly lower in the premarket session on Friday after the fertilizer giant released preliminary segment volumes for the third quarter of fiscal 2025. Operational challenges within the Phosphate division were the core driver behind the decline, despite positive sequential movement in other segments. The Phosphate segment disclosed third-quarter sales volumes of $1.6 million...
Form 8.3 - American Axle & Manufacturing Holdings Inc
Form 8.3 - American Axle & Manufacturing Holdings Inc
Oct 10, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Arrowstreet Capital, Limited Partnership (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Crispr Says CTX460 for Alpha-1 Antitrypsin Deficiency Treatment Shows 'Durable Effects' in Preclinical Studies
Crispr Says CTX460 for Alpha-1 Antitrypsin Deficiency Treatment Shows 'Durable Effects' in Preclinical Studies
Oct 10, 2025
08:55 AM EDT, 10/10/2025 (MT Newswires) -- Crispr Therapeutics ( CRSP ) said Friday that its alpha-1 antitrypsin deficiency treatment program, called CTX460, showed specific and durable effects in preclinical studies. Data demonstrated that a single dose of CTX460 resulted in significant, dose-dependent correction of liver deoxyribonucleic acid or DNA in both rat and mouse AATD models, as well as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved